ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 152 filers reported holding ARCUS BIOSCIENCES INC in Q1 2021. The put-call ratio across all filers is 3.92 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $225,329 | -51.6% | 10,896 | -38.7% | 0.00% | 0.0% |
| Q3 2022 | $466,000 | -91.9% | 17,784 | -92.2% | 0.00% | -91.7% |
| Q2 2022 | $5,782,000 | +2.6% | 228,247 | +27.8% | 0.01% | +9.1% |
| Q1 2022 | $5,637,000 | +46.2% | 178,565 | +30.1% | 0.01% | -38.9% |
| Q1 2021 | $3,855,000 | -9.3% | 137,283 | -16.1% | 0.02% | -21.7% |
| Q4 2020 | $4,248,000 | +12037.1% | 163,646 | +6320.0% | 0.02% | – |
| Q1 2020 | $35,000 | -85.9% | 2,549 | -88.9% | 0.00% | -100.0% |
| Q4 2018 | $249,000 | -49.6% | 23,065 | -34.9% | 0.00% | +50.0% |
| Q3 2018 | $494,000 | – | 35,446 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $50,877,000 | 22.64% |
| Octagon Capital Advisors LP | 2,489,974 | $78,584,000 | 16.99% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $27,451,000 | 8.41% |
| BVF INC/IL | 3,960,948 | $125,008,000 | 5.00% |
| PFM Health Sciences, LP | 3,431,010 | $108,283,000 | 4.05% |
| EcoR1 Capital, LLC | 3,265,101 | $103,047,000 | 3.22% |
| Alphabet Inc. | 2,563,441 | $80,902,000 | 2.62% |
| Boxer Capital, LLC | 1,432,200 | $45,200,000 | 2.32% |
| SECTORAL ASSET MANAGEMENT INC | 338,480 | $10,682,000 | 1.90% |
| PARK CIRCLE Co | 64,000 | $2,020,000 | 1.68% |